BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3086235)

  • 21. C5 fragments: are they important in polymorphonuclear leucocyte diapedesis?
    Russo M; Arruda AM; Jancar S
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):361-9. PubMed ID: 3738213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice.
    Howell GR; Soto I; Ryan M; Graham LC; Smith RS; John SW
    J Neuroinflammation; 2013 Jun; 10():76. PubMed ID: 23806181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of intravascular complement activation and brief episodes of hypoxia on protein in bronchoalveolar lavage fluid in C5 sufficient and deficient mice.
    Larsen GL; Presley DM; Graves JP; Giclas PC
    Pediatr Pulmonol; 1991; 11(4):302-9. PubMed ID: 1758754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity.
    Tsuji RF; Kikuchi M; Askenase PW
    J Immunol; 1996 Jun; 156(12):4444-50. PubMed ID: 8648091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of the early events contributing to zymosan-induced multiple organ dysfunction syndrome using MIP-1alpha, C3 knockout, and C5-deficient mice.
    Mahesh J; Daly J; Cheadle WG; Kotwal GJ
    Shock; 1999 Nov; 12(5):340-9. PubMed ID: 10565608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication rate of Pseudomonas aeruginosa in the murine lung.
    Sordelli DO; Cerquetti MC; Hooke AM
    Infect Immun; 1985 Nov; 50(2):388-91. PubMed ID: 3932207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung.
    Sordelli DO; Zeligs BJ; Cerquetti MC; Morris Hooke A; Bellanti JA
    Eur J Respir Dis; 1985 Jan; 66(1):31-9. PubMed ID: 3920067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic defect in secretion of complement C5 in mice.
    Ooi YM; Colten HR
    Nature; 1979 Nov; 282(5735):207-8. PubMed ID: 492335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.
    Sordelli DO; Cerquetti MC; Morris Hooke A; Bellanti JA
    Infect Immun; 1985 Aug; 49(2):265-9. PubMed ID: 3926643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans.
    Lovchik JA; Lipscomb MF
    Am J Respir Cell Mol Biol; 1993 Dec; 9(6):617-27. PubMed ID: 8257594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5 gene influences the development of murine myasthenia gravis.
    Christadoss P
    J Immunol; 1988 Apr; 140(8):2589-92. PubMed ID: 3356901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic control of susceptibility to Cryptococcus neoformans in mice.
    Rhodes JC; Wicker LS; Urba WJ
    Infect Immun; 1980 Aug; 29(2):494-9. PubMed ID: 7216421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C5 does not play a major role in the immune response of mice to SRBC in vivo.
    van den Berg CW; van Horssen PJ; Hofhuis FM; Aerts PC; van Dijk H
    Scand J Immunol; 1991 May; 33(5):621-6. PubMed ID: 2031152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host defense mechanisms against pneumonia due to Pseudomonas aeruginosa.
    Pennington JE; Ehrie MG; Hickey WF
    Rev Infect Dis; 1984; 6 Suppl 3():S657-66. PubMed ID: 6443767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic control of lipopolysaccharide-induced mobilization of CFUs. Dissociation between early and delayed mobilization of CFUs in complement C5-deficient mice and LPS non-responder mice.
    Benner R; Rijnbeek AM; Molendijk W; Vos O
    Cell Tissue Kinet; 1981 Mar; 14(2):143-51. PubMed ID: 7471163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pulmonary response of C5 sufficient and deficient mice to immune complexes.
    Larsen GL; Mitchell BC; Henson PM
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):434-9. PubMed ID: 6452843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component.
    Lyon FL; Hector RF; Domer JE
    J Med Vet Mycol; 1986 Oct; 24(5):359-67. PubMed ID: 3537260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice.
    Evans R
    Int J Cancer; 1980 Aug; 26(2):227-9. PubMed ID: 7203715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of C5-mediated mechanisms to host defence against Echinococcus granulosus hydatid infection.
    Ferreira AM; Breijo M; Sim RB; Nieto A
    Parasite Immunol; 2000 Sep; 22(9):445-53. PubMed ID: 10972851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.